Mounjaro Injections – Tirzepatide Injection Product Specification

Tirzepatide injection is a prescription injectable medicine administered subcutaneously once weekly. It belongs to a class of medicines that act on both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. In the United States, tirzepatide-containing prescription medicines are approved for specific medical uses, including improving blood sugar control in people with type 2 diabetes and, depending on the specific FDA-approved product, chronic weight management or obstructive sleep apnea in certain adults.

For people searching online for tirzepatide injections in the USA, it is important to verify the product, strength, prescription status, and source before use. FDA-approved tirzepatide products are prescription medicines and should be used under the supervision of a qualified healthcare professional.

Tirzepatide Injection Product Specification

Specification Details

Active Ingredient Tirzepatide

Dosage Form Injection

Administration Subcutaneous injection

Available Strengths 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg

Typical Frequency Once weekly, according to the prescribed regimen

Storage Follow the product-specific prescribing information

Prescription Status Prescription medicine in the USA

FDA labeling lists tirzepatide injection strengths of 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg per 0.5 mL for certain presentations.

Tirzepatide Injection Strengths

The 2.5 mg strength is generally used as the initial dose for adults under the applicable FDA-approved prescribing information. Dose increases are made gradually and only according to the healthcare professional's instructions. Depending on the indication, maintenance doses can include 5 mg, 10 mg, or 15 mg once weekly, while 7.5 mg and 12.5 mg strengths may be used during dose escalation. The maximum recommended dose is 15 mg once weekly for the applicable adult indications.

Tirzepatide should not be combined with another tirzepatide-containing medicine or a GLP-1 receptor agonist unless specifically directed by a healthcare professional.

Important Safety Information

Tirzepatide carries important safety warnings. It is contraindicated in people with a personal or family history of medullary thyroid carcinoma or in patients with Multiple Endocrine Neoplasia syndrome type 2. Serious hypersensitivity reactions have also been reported. Other warnings include gastrointestinal adverse reactions, pancreatitis, gallbladder disease, kidney injury related to dehydration, hypoglycemia when used with certain diabetes medicines, and other risks described in the prescribing information.

Common adverse reactions can include nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion, and abdominal discomfort.

Frequently Asked Questions

What is tirzepatide injection?

Tirzepatide is a prescription medicine that activates GIP and GLP-1 receptors. Depending on the specific approved product and indication, it is used for blood sugar management in type 2 diabetes or certain weight-management and sleep-apnea indications.

What strengths are available?

The commonly listed injection strengths are 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg per 0.5 mL for applicable presentations.

How often is tirzepatide injected?

For approved adult indications, tirzepatide is administered once weekly. The exact dose and schedule should be determined by the prescribing healthcare professional.

Is tirzepatide available in the USA without a prescription?

FDA-approved tirzepatide products are prescription medicines. Consumers should obtain them through appropriate licensed healthcare and pharmacy channels.

Can I choose the strength myself?

No. The appropriate strength depends on the approved indication, treatment response, tolerability, and medical history. Dose changes should be made only under professional medical supervision.

Where can I verify tirzepatide injection information?

Patients and healthcare professionals should refer to the current FDA-approved prescribing information and consult a licensed healthcare professional for individualized advice.

Medical Disclaimer: This page is provided for general educational and product-information purposes and is not a substitute for medical advice, diagnosis, or treatment. Tirzepatide is a prescription medicine. Patients should consult a qualified healthcare professional before starting, changing, or stopping treatment.